Liver Metastases in Prostate Carcinoma Represent a Relatively Aggressive Subtype Refractory to Hormonal Therapy and Short-Duration Response to Docetaxel Monotherapy

World Journal of Oncology - Canada
doi 10.14740/wjon903w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elmer Press, Inc.

Related search

Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel

Japanese Journal of Urology
Urology
2013English

Remarkable Response to Abiraterone Acetate in Castration-Resistant Prostate Cancer Patient With Aggressive Liver Metastasis

IJU Case Reports
2018English

Neurocardiogenic Syncope: Response to Hormonal Therapy. 2

Pediatric Research
Child HealthPediatricsPerinatology
1996English

Measurement of Response to Treatment in Colorectal Liver Metastases

British Journal of Cancer
Cancer ResearchOncology
1995English

Vegetational Response to Short-Duration and Continuous Grazing in Southcentral New Mexico

Journal of Range Management
1991English

Prostate-Specific Antigen Response to Withdrawal of Megestrol Acetate in a Patient With Hormone-Refractory Prostate Cancer

Mayo Clinic Proceedings
Medicine
1997English

Prostate-Specific Antigen Response to Withdrawal of Megestrol Acetate in a Patient With Hormone-Refractory Prostate Cancer

Mayo Clinic Proceedings
Medicine
1997English

Conversion of Unresectable to Resectable Liver Metastases From Colorectal Carcinoma Using Hepatic Arterial Chronomodulated Chemotherapy: A Case Report and Short Literature Review

Surgical Science
2018English

Prostate Apoptosis Response-4 Is Involved in the Apoptosis Response to Docetaxel in McF-7 Breast Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy